Candel Therapeutics, Inc.
CADL
$8.62
-$0.10-1.15%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
5/13/2026
-
Globe Newswire
5/12/2026
-
Tickeron - Stocks
5/11/2026
-
MarketBeat
5/8/2026
-
The Cerbat Gem
5/7/2026
-
MarketBeat
5/5/2026
-
MarketBeat
5/5/2026
-
MarketBeat
5/4/2026
-
MarketBeat
5/4/2026
-
Globe Newswire
5/4/2026
-
Nasdaq News: Markets
5/1/2026
-
Globe Newswire
4/29/2026
-
Proactive Investors - UK
4/29/2026
-
Proactive Investors - UK
4/29/2026
-
Globe Newswire
4/25/2026
-
Tickeron - Technical Analysis
4/21/2026
-
SeekingAlpha
4/21/2026
-
Seeking Alpha - Healthcare
4/21/2026
-
Seeking Alpha - Long Ideas
4/20/2026
-
Benzinga
4/20/2026
-
MarketBeat
4/20/2026
-
Stocktwits News Feed
4/18/2026
-
Tickeron - Stocks
4/18/2026
-
Tickeron - Stocks
4/17/2026
-
Zolmax
4/14/2026
-
Tickeron - Stocks
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, March 12, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of May 11 and 15 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
617 916 5445
Address
117 Kendrick Street
Needham, MA 02494
Needham, MA 02494
Country
Year Founded
Business Description
Sector
Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies for cancer patients. It develops CAN-2409, which is in Phase 2a clinical trials for the treatment...
more